Envoy Medical (COCH) Common Equity (2022 - 2025)
Historic Common Equity for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to -$7.7 million.
- Envoy Medical's Common Equity rose 5868.52% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.7 million, marking a year-over-year increase of 5868.52%. This contributed to the annual value of -$18.8 million for FY2024, which is 96092.34% down from last year.
- According to the latest figures from Q3 2025, Envoy Medical's Common Equity is -$7.7 million, which was up 5868.52% from -$29.9 million recorded in Q2 2025.
- In the past 5 years, Envoy Medical's Common Equity registered a high of $4.8 million during Q3 2023, and its lowest value of -$47.5 million during Q1 2023.
- Its 4-year average for Common Equity is -$20.5 million, with a median of -$18.8 million in 2024.
- Per our database at Business Quant, Envoy Medical's Common Equity soared by 12758.31% in 2023 and then tumbled by 96092.34% in 2024.
- Envoy Medical's Common Equity (Quarter) stood at -$36.2 million in 2022, then soared by 95.09% to -$1.8 million in 2023, then plummeted by 960.92% to -$18.8 million in 2024, then surged by 59.34% to -$7.7 million in 2025.
- Its Common Equity was -$7.7 million in Q3 2025, compared to -$29.9 million in Q2 2025 and -$24.2 million in Q1 2025.